Evidence method
Level · gp.fundamentals.debt_to_revenue
216.12% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TELA · Sep 30, 2024
TELA Bio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001558370-24-015050General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.64% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-47.39% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
25.94% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
71.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
67.83% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-49.40% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.91% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.70% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesHistory building
Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 253.66%
- Current
- 216.12%
- Delta
- -37.54%
- Previous
- 1.86%
- Current
- 0.64%
- Delta
- -1.21%
- Previous
- -66.48%
- Current
- -47.39%
- Delta
- 19.09%
- Previous
- 11.02%
- Current
- 25.94%
- Delta
- 14.93%
- Previous
- 83.10%
- Current
- 71.74%
- Delta
- -11.36%
- Previous
- 68.81%
- Current
- 67.83%
- Delta
- -0.99%
- Previous
- -71.90%
- Current
- -49.40%
- Delta
- 22.50%
- Previous
- 14.44%
- Current
- 10.91%
- Delta
- -3.53%
- Previous
- 6.77%
- Current
- 5.70%
- Delta
- -1.07%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TELA Fundamental State →Has State · TELA Bio, Inc. →Transitioned To · TELA Fundamental State →Transitioned To · TELA BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · TELA CAPEX_INTENSITY_DECREASED →Transitioned To · TELA CASH_GENERATION_INCREASED →Transitioned To · TELA GROWTH_INCREASED →Transitioned To · TELA INVENTORY_PRESSURE_DECREASED →Transitioned To · TELA MARGIN_DECREASED →Transitioned To · TELA PROFITABILITY_INCREASED →Transitioned To · TELA R_AND_D_INTENSITY_DECREASED →Transitioned To · TELA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.